The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EORTC CLTF 2018 | High-throughput sequencing to inform mycosis fungoides management
Robert Gniadecki, MD, PhD, of the University of Alberta, Edmonton, Canada, discusses his group’s research into high-throughput sequencing, particularly of the T-cell receptor (TCR) region, in mycosis fungoides, the most common type of cutaneous T-cell lymphoma. Dr Gniadecki then highlights the potential implications of these results for the management of the disease. This video was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.
